Search results
Results from the WOW.Com Content Network
Trachoma is an infectious disease caused by bacterium Chlamydia trachomatis. [2] The infection causes a roughening of the inner surface of the eyelids. [2] This roughening can lead to pain in the eyes, breakdown of the outer surface or cornea of the eyes, and eventual blindness. [2]
Chlamydia trachomatis (/ k l ə ˈ m ɪ d i ə t r ə ˈ k oʊ m ə t ɪ s /) is a Gram-negative, anaerobic bacterium responsible for chlamydia and trachoma. C. trachomatis exists in two forms, an extracellular infectious elementary body (EB) and an intracellular non-infectious reticulate body (RB). [2]
Trachoma is a chronic conjunctivitis caused by Chlamydia trachomatis. [20] It was once the leading cause of blindness worldwide, but its role diminished from 15% of blindness cases by trachoma in 1995 to 3.6% in 2002. [21] [22] The infection can be spread from eye to eye by fingers, shared towels or cloths, coughing and sneezing and eye-seeking ...
Arlt's line is a characteristic finding of trachoma, an infection of the eye caused by Chlamydia trachomatis. [2] The line runs horizontally, parallel to eyelid, and is found at the junction of the anterior one third and posterior two thirds of the conjunctiva. [1] The line is named after the Austrian ophthalmologist Carl Ferdinand von Arlt.
Tetracyclines remain the treatment of choice for infections caused by chlamydia (trachoma, psittacosis, salpingitis, urethritis and L. venereum infection), Rickettsia (typhus, Rocky Mountain spotted fever), brucellosis and spirochetal infections (Lyme disease/borreliosis and syphilis). [2] They are also used in veterinary medicine. [2]
The World Health Organisation announced a few weeks ago that it had validated Malawi’s elimination of trachoma as a public health issue.
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
350 Miles For Treatment. A HuffPo investigation into the dearth of treatment options available to opiate addicts living in rural America. The Subsidy Gap.